MedPath

Clinical usefulness of virtual ablation guided catheter ablation of atrial fibrillation: prospective randomized study II (Virtual rotor mapping and catheter ablation) CUVIA-AF II”

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0003613
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
660
Inclusion Criteria

legal age over 19 years old or capable of providing consent for the target according to national law
- Patients undergoing atrial fibrillation electrode ceramic resection in accordance with treatment guidelines, or patients who need electrode ceramic resection again due to recurrence or recurrence after maze surgery
- Patients who meet the HIRA's criteria for atrial fibrillation re-treatment
- Patients who are free from adverse reactions, economic problems, and other anticoagulants

Exclusion Criteria

- Patients who are scheduled to receive atrial fibrillation, but do not agree with this study and do not want to register
- Older patients over 81 years of age
- The patient who have renal disease of eGFR<30mL/min
- Patients with other vascular diseases that require maintenance of antiplatelet drugs other than anticoagulants during treatment
- Patients who have difficulty performing atrial fibrillation in a conventional manner due to structural abnormalities of the heart
- Patients who have previously experienced major hemorrhagic complications from the use of anticoagulants
- The patient who have risk of ischemic cerebral infarction (CHA2DS2-VASc Score >5)
- The patient have experienced ischemic cerebral infarction more 2 times
- Atrial fibrillation patients accompanying structural heart disease with severe heart disease or hemodynamic effects
- The patients who missed out to recording of 3D CT, echo and electrocardiography.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of ischemic cerebral infarction;rate of hospitalization;recurrence rate of atrial fibrillation;mortality
Secondary Outcome Measures
NameTimeMethod
Major complication associated with the procedure : complication of hemorrhagic and embolic;Procedure time and Radiofrequency ablation time
© Copyright 2025. All Rights Reserved by MedPath